Charles River Labs, NCI, Pall, Ciphergen, Invitrogen, Mayo Clinic, Separation Scientific, PerkinElmer, Bio Asia, Kyorin Pharmaceutical, AAAS | GenomeWeb

Charles River Labs to Shut Down Proteomics Service Joint Venture with Proteome Systems

Charles River Laboratories will close its proteomics joint venture with Proteome Systems, the company said this week.

The company decided to close Charles River Proteomic Sevices after less than two years of operation because it “has not achieved its strategic goals,” according to a company statement.

The closure is part of a reorganization of Charles River’s Worcester-based division and the integration of its preclinical services organization.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.